BNP Paribas Financial Markets Buys 212,545 Shares of Trupanion, Inc. (NASDAQ:TRUP)

BNP Paribas Financial Markets raised its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 170.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 337,093 shares of the financial services provider’s stock after acquiring an additional 212,545 shares during the period. BNP Paribas Financial Markets owned approximately 0.80% of Trupanion worth $16,248,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Freestone Grove Partners LP bought a new position in Trupanion during the 4th quarter valued at about $7,776,000. Baillie Gifford & Co. grew its stake in shares of Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock valued at $33,806,000 after buying an additional 147,341 shares during the last quarter. First Trust Advisors LP bought a new position in shares of Trupanion during the fourth quarter valued at approximately $7,083,000. Dimensional Fund Advisors LP raised its holdings in shares of Trupanion by 112.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider’s stock worth $13,204,000 after buying an additional 144,828 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in shares of Trupanion by 458.3% during the 4th quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock worth $7,620,000 after acquiring an additional 129,782 shares during the last quarter.

Insider Buying and Selling at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now directly owns 2,416 shares of the company’s stock, valued at approximately $82,675.52. The trade was a 36.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the company’s stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $4,415,201.28. The trade was a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,792 shares of company stock worth $1,122,802 over the last quarter. Insiders own 5.50% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on TRUP. Lake Street Capital reduced their target price on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Stifel Nicolaus reduced their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Finally, Piper Sandler lowered their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Trupanion currently has a consensus rating of “Moderate Buy” and an average target price of $51.80.

Trupanion Price Performance

Shares of TRUP opened at $44.31 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The company has a 50 day moving average price of $36.70 and a 200-day moving average price of $44.61. Trupanion, Inc. has a fifty-two week low of $25.07 and a fifty-two week high of $57.90. The stock has a market capitalization of $1.90 billion, a PE ratio of -192.65, a PEG ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The business had revenue of $341.98 million for the quarter, compared to analysts’ expectations of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business’s revenue for the quarter was up 11.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.16) EPS. Equities analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.